NCT03601442
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03601442
Title Managed Access Programs for CTL019, Tisagenlecleucel
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult | child
Covered Countries


No variant requirements are available.